Review of risperidone for the treatment of pediatric and adolescent bipolar disorder and schizophrenia
Jeffrey R Bishop1,2, Mani N Pavuluri21Department of Pharmacy Practice, University of Illinois at Chicago College of Pharmacy, Chicago, IL, USA; 2Department of Psychiatry, Pediatric Mood Disorders Program and Center for Cognitive Medicine, University of Illinois at Chicago College of Medicine, Chicag...
Saved in:
Main Authors: | Jeffrey R Bishop, Mani N Pavuluri |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2008
|
Subjects: | |
Online Access: | https://doaj.org/article/114fb8b9e4014c84a4a5f1d80a3208a2 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Risperidone treatment for ADHD in children and adolescents with bipolar disorder
by: Joseph Biederman, et al.
Published: (2008) -
Comparison of somnolence associated with asenapine, olanzapine, risperidone, and haloperidol relative to placebo in patients with schizophrenia or bipolar disorder
by: Gao K, et al.
Published: (2013) -
Risperidone in the treatment of behavioral disorders associated with autism in children and adolescents
by: Roberto Canitano, et al.
Published: (2008) -
Emerging treatments in the management of bipolar disorder – focus on risperidone long acting injection
by: Wissam El-Hage, et al.
Published: (2010) -
Olanzapine approved for the acute treatment of schizophrenia or manic/mixed episodes associated with bipolar I disorder in adolescent patients
by: Ann E Maloney, et al.
Published: (2010)